Investor Presentation 1Q 2025 Copyright © 2025 ModivCare® Solutions LLC 1 Forward Looking Statements Certain statements contained herein constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are frequently identified by the use of terms such as "may," "will," "should," "expect," "believe," "estimate," "intend," and similar words indicating possible future expectations, events or actions. The updated g ...

ModivCare (MODV) came out with a quarterly loss of $1.71 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -402.94%. A quarter ago, it was expected that this provider of government-sponsored social services would post a loss of $0.10 per share when it actually produced earnings of $0.19, delivering a surprise of 290%.Over the last fo ...

ModivCare (MODV) Q1 2025 Earnings Call May 08, 2025 05:00 PM ET Speaker0 Good day, everyone, and welcome to Motive Care's First Quarter twenty twenty five Financial Results Conference Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. Please note this conference call is being recorded. Today's speaker will be Hugh Sampson, MotiveCare's President and Chief Executive Officer. Before we get started, I want to remind everyone that d ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 86-0845127 (State or other jurisdiction of ...

Modivcare Reports First Quarter 2025 Financial Results Denver, CO – May 8, 2025 – Modivcare Inc. (the "Company" or "Modivcare") (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three months ended March 31, 2025. "In Q1, we continued to advance our strategic objectives and operational initiatives," said L. Heath Sampson, President and CEO. "Company-wi ...

Core Viewpoint - Grabar Law Office is investigating claims on behalf of ModivCare, Inc. shareholders regarding potential breaches of fiduciary duties by certain officers of the company [1] Group 1: Shareholder Actions - Current ModivCare shareholders who held shares prior to November 3, 2022, can seek corporate reforms, return of funds, and a court-approved incentive award at no cost [2][5] Group 2: Allegations of Misconduct - A securities fraud class action complaint alleges that ModivCare misled the market about the risks associated with contracts in its non-emergency medical transportation segment, which negatively impacted free cash flow [3] - Defendants allegedly failed to disclose that certain contracts caused deterioration in free cash flow, leading to negative impacts on adjusted EBITDA, liquidity issues, and misleading positive statements about the company's operations and prospects [4]

Core Viewpoint - ModivCare Inc. is facing a class action lawsuit due to allegations of false statements and concealment of information that negatively impacted the company's financial performance, particularly in its Non-Emergency Medical Transportation (NEMT) segment [3]. Group 1: Allegations and Financial Impact - The lawsuit claims that certain contracts in ModivCare's NEMT segment led to a deterioration in the company's free cash flow [3]. - It is alleged that contract renegotiations and pricing accommodations adversely affected the company's adjusted EBITDA [3]. - The company reportedly faced liquidity issues as a result of these factors, and the defendants' positive statements about the company's business were misleading [3]. Group 2: Class Action Details - The class period for the lawsuit is defined as November 3, 2022, to September 15, 2024 [3]. - Shareholders who purchased shares during this period are encouraged to register for participation in the class action, with a deadline set for March 31, 2025 [4]. - There is no cost or obligation for shareholders to participate in the case, and they will receive updates through a portfolio monitoring software once registered [4]. Group 3: Law Firm Information - The Gross Law Firm is leading the class action and is recognized for its commitment to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ModivCare To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in ModivCare between November 3, 2022 and May 3, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, March 28, 2025 /PRNewswir ...

NEW YORK, March 28, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ModivCare Inc. ("ModivCare" or the "Company") (NASDAQ: MODV) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ModivCare investors who were adversely affected by alleged securities fraud between November 3, 2022 and September 15, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/modivcare-inc-lawsuit-subm ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased ModivCare Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the ModivCare securities is from November 3, 2022, to September 15, 2024 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [2][5]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions [3]. - Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time [3]. - The firm has consistently ranked highly in securities class action settlements, recovering hundreds of millions of dollars for investors [3]. Group 3: Case Allegations - The lawsuit alleges that ModivCare's defendants made materially false and misleading statements and failed to disclose adverse facts about the company's business and operations [4]. - Specific issues cited include the deterioration of free cash flow in ModivCare's non-emergency medical transportation segment, which negatively impacted adjusted EBITDA and liquidity [4]. - The lawsuit claims that when the true details were revealed, investors suffered damages due to the misleading statements [4].